epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aplenzin
    bupropion hydrobromide
  • remove Bonjesta
    doxylamine/ pyridoxine
  • remove Drysol
    aluminum chloride topical
  • remove Kyleena
    levonorgestrel intrauterine device
  • remove lovastatin
    generic
  • remove Viokace
    pancrelipase
  • remove Wakix
    pitolisant

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Bonjesta (doxylamine/ pyridoxine) + Wakix (pitolisant)

Avoid/Use Alternative


doxylamine + pitolisant

avoid combo: combo may decr. efficacy of both drugs (antagonistic effects)

Monitor/Modify Tx

Smiley face Smiley face Aplenzin (bupropion hydrobromide) + Wakix (pitolisant)

Monitor/Modify Tx


bupropion + pitolisant

monitor ECG; if adding bupropion to stable pitolisant tx, decr. pitolisant dose by 50%; if adding pitolisant to existing bupropion tx in PEDS PTS <40kg: adjust pitolisant max dose to 8.9 mg qd; ADULTS and PEDS PTS 40kg or more: adjust pitolisant max dose to 17.8 mg qd: combo may incr. pitolisant levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (hepatic metabolism inhibited)

Caution Advised

Smiley face Smiley face Kyleena (levonorgestrel intrauterine device) + Wakix (pitolisant)

Caution Advised


levonorgestrel intrauterine device (contraceptive) + pitolisant

caution advised: combo may decr. levonorgestrel levels, contraceptive efficacy (hepatic metabolism possibly induced)

Additional Considerations

Smiley face Smiley face bupropion in Aplenzin

caution advised with concomitant drugs if smoking cessation use; dose adjustments may be necessary; smoking cessation may alter pharmacokinetics or pharmacodynamics of certain drugs

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information